ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut

209
82
Favorite

ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut

investorplace2021-06-18

23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday. Here’s everything investorsneed to know about the company and it going public. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

209

Report

Comment（82）

Shuanggyang
·2021-06-21
[財迷]
Reply
Like
Report
EricTan4527
·2021-06-21
Oh
Reply
Like
Report
Popcornn
·2021-06-21
Wow
Reply
Like
Report
jolinisme
·2021-06-21
Oh
Reply
Like
Report
WhinnyWinny
·2021-06-20
[Great]
Reply
Like
Report
Wongwonggg
·2021-06-20
Good
Reply
Like
Report
KS_Lee
·2021-06-20
All biotech companies are risky but also potentially jackpot material
Reply
Like
Report
JimmyLZH
·2021-06-20
Nice
Reply
2
Report
GeoLegends
·2021-06-20
Nice
Reply
1
Report
Brosnananana
·2021-06-20
Nice
Reply
1
Report
ArkInvest
·2021-06-20
nice
Reply
1
Report
KevinWan
·2021-06-20
Thanks
Reply
1
Report
gary9535
·2021-06-20
WOW
Reply
1
Report
ISSEY1413
·2021-06-20
Follow me. If you want to know how to complete "Trending" tigercoin task
Reply
1
Report
Kaibin
·2021-06-20
[Cool]
Reply
1
Report
ML808
·2021-06-20
Good advice!
Reply
1
Report
Hayleywills
·2021-06-20
Interesting
Reply
1
Report
NgKenny
·2021-06-20
Good
Reply
Like
Report
Magthemoney
·2021-06-19
[Smile] [Strong]
Reply
Like
Report
jyau73
·2021-06-19
Huat and cool
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1135760972?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-18 22:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135760972","market":"us","top_or_hot":-1,"title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","media":"investorplace","content":"<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ME","symbol_name":"23andMe, Inc.","start_time":0,"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","article_id":"1135760972","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","pubTimestamp":1624026807,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ME":"23andMe, Inc."},"translate_title":"《我的股票》:23andMe纳斯达克上市后投资者应了解的14件事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ME":0.9},"content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":164433705,"gmtCreate":1624232732707,"gmtModify":1703830919328,"author":{"id":"3574887418287176","authorId":"3574887418287176","name":"Shuanggyang","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574887418287176","authorIdStr":"3574887418287176"},"htmlText":"[財迷]&nbsp;","listText":"[財迷]&nbsp;","text":"[財迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164433705","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":164524408,"gmtCreate":1624231011004,"gmtModify":1703830841221,"author":{"id":"3586315254285458","authorId":"3586315254285458","name":"EricTan4527","avatar":"https://static.tigerbbs.com/d44236c4ebf7d2188154b3ab2c05456a","vip":1,"crmLevel":7,"crmLevelSwitch":1,"idStr":"3586315254285458","authorIdStr":"3586315254285458"},"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164524408","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164505132,"gmtCreate":1624226013326,"gmtModify":1703830752982,"author":{"id":"3574394359789498","authorId":"3574394359789498","name":"Popcornn","avatar":"https://static.tigerbbs.com/a9963e628c84bc7aa6308556a38d7360","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574394359789498","authorIdStr":"3574394359789498"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164505132","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164265532,"gmtCreate":1624209300626,"gmtModify":1703830691328,"author":{"id":"3574936536300157","authorId":"3574936536300157","name":"jolinisme","avatar":"https://static.tigerbbs.com/1091498047118bdffdd80375a3e55929","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3574936536300157","authorIdStr":"3574936536300157"},"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164265532","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164640569,"gmtCreate":1624203396451,"gmtModify":1703830587704,"author":{"id":"3583917916714733","authorId":"3583917916714733","name":"WhinnyWinny","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3583917916714733","authorIdStr":"3583917916714733"},"htmlText":"[Great]&nbsp;","listText":"[Great]&nbsp;","text":"[Great]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164640569","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164808406,"gmtCreate":1624187440905,"gmtModify":1703830344587,"author":{"id":"3586849282716963","authorId":"3586849282716963","name":"Wongwonggg","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586849282716963","authorIdStr":"3586849282716963"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164808406","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164132238,"gmtCreate":1624178847024,"gmtModify":1703830236168,"author":{"id":"3579578865458065","authorId":"3579578865458065","name":"KS_Lee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579578865458065","authorIdStr":"3579578865458065"},"htmlText":"All biotech companies are risky but also potentially jackpot material&nbsp;","listText":"All biotech companies are risky but also potentially jackpot material&nbsp;","text":"All biotech companies are risky but also potentially jackpot material","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164132238","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165469350,"gmtCreate":1624155088870,"gmtModify":1703829585572,"author":{"id":"3586863844711073","authorId":"3586863844711073","name":"JimmyLZH","avatar":"https://static.tigerbbs.com/7ecc6de8a47b65c54bcbdca5fe23b697","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":2,"crmLevelSwitch":0,"idStr":"3586863844711073","authorIdStr":"3586863844711073"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165469350","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165413603,"gmtCreate":1624154702302,"gmtModify":1703829557771,"author":{"id":"3584748254057781","authorId":"3584748254057781","name":"GeoLegends","avatar":"https://static.tigerbbs.com/9b58fc6a4f5903eabaf4a377779a7a2f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3584748254057781","authorIdStr":"3584748254057781"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165413603","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165437577,"gmtCreate":1624154639199,"gmtModify":1703829554819,"author":{"id":"3578737755692245","authorId":"3578737755692245","name":"Brosnananana","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3578737755692245","authorIdStr":"3578737755692245"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165437577","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165584651,"gmtCreate":1624151714573,"gmtModify":1703829440138,"author":{"id":"3559463359065359","authorId":"3559463359065359","name":"ArkInvest","avatar":"https://static.tigerbbs.com/6dfcf7df27430673110d69ba1374e540","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3559463359065359","authorIdStr":"3559463359065359"},"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165584651","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165589039,"gmtCreate":1624151403321,"gmtModify":1703829429258,"author":{"id":"3586164795006867","authorId":"3586164795006867","name":"KevinWan","avatar":"https://static.tigerbbs.com/69d530508883f388a4a626340300ed5a","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3586164795006867","authorIdStr":"3586164795006867"},"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165589039","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165508258,"gmtCreate":1624149911274,"gmtModify":1703829379574,"author":{"id":"3586300229783457","authorId":"3586300229783457","name":"gary9535","avatar":"https://static.tigerbbs.com/450bffc6ea7d58c21b47fcc86060b0d4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586300229783457","authorIdStr":"3586300229783457"},"htmlText":"WOW","listText":"WOW","text":"WOW","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165508258","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165252200,"gmtCreate":1624148600900,"gmtModify":1703829341491,"author":{"id":"3580024367177542","authorId":"3580024367177542","name":"ISSEY1413","avatar":"https://static.tigerbbs.com/3aae359514ad4455bfc28cf62f608a5e","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":6,"crmLevelSwitch":1,"idStr":"3580024367177542","authorIdStr":"3580024367177542"},"htmlText":"Follow me. If you want to know how to complete \"Trending\" tigercoin task","listText":"Follow me. If you want to know how to complete \"Trending\" tigercoin task","text":"Follow me. If you want to know how to complete \"Trending\" tigercoin task","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165252200","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165264814,"gmtCreate":1624147597138,"gmtModify":1703829315910,"author":{"id":"3561084317650470","authorId":"3561084317650470","name":"Kaibin","avatar":"https://static.tigerbbs.com/b73a11c3a24271721d07c8c1d1c6242c","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3561084317650470","authorIdStr":"3561084317650470"},"htmlText":"[Cool]&nbsp;","listText":"[Cool]&nbsp;","text":"[Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165264814","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165671394,"gmtCreate":1624141918718,"gmtModify":1703829224687,"author":{"id":"3582359360248748","authorId":"3582359360248748","name":"ML808","avatar":"https://static.tigerbbs.com/f601c68849ffbac8b7679f40f1471368","vip":1,"hat":"https://static.tigerbbs.com/7b75ce0c34afff716602792a5d0929dd","crmLevel":4,"crmLevelSwitch":0,"idStr":"3582359360248748","authorIdStr":"3582359360248748"},"htmlText":"Good advice!","listText":"Good advice!","text":"Good advice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165671394","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165664994,"gmtCreate":1624130690418,"gmtModify":1703829175909,"author":{"id":"3574919372586068","authorId":"3574919372586068","name":"Hayleywills","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574919372586068","authorIdStr":"3574919372586068"},"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165664994","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165843650,"gmtCreate":1624119226270,"gmtModify":1703829072508,"author":{"id":"3582778356971864","authorId":"3582778356971864","name":"NgKenny","avatar":"https://static.tigerbbs.com/4fdae3e0bdca8d3a33e7f9d619f0dc88","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":1,"idStr":"3582778356971864","authorIdStr":"3582778356971864"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165843650","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165315735,"gmtCreate":1624095429727,"gmtModify":1703828747072,"author":{"id":"3587012591464862","authorId":"3587012591464862","name":"Magthemoney","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3587012591464862","authorIdStr":"3587012591464862"},"htmlText":"[Smile]&nbsp;[Strong]&nbsp;","listText":"[Smile]&nbsp;[Strong]&nbsp;","text":"[Smile] [Strong]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165315735","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":165966057,"gmtCreate":1624088054479,"gmtModify":1703828631034,"author":{"id":"4087190501410390","authorId":"4087190501410390","name":"jyau73","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4087190501410390","authorIdStr":"4087190501410390"},"htmlText":"Huat and cool","listText":"Huat and cool","text":"Huat and cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/165966057","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://ttm.financial/m/news/1135760972?lang=&edition=fundamental","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":209,"commentSize":82,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}